Page last updated: 2024-09-05

sb 203580 and Peritonitis

sb 203580 has been researched along with Peritonitis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wu, H; Zhang, L; Zhang, Z; Zhou, C1
Fukuda, Y; Goto, M; Terakawa, M; Tomimori, Y1

Other Studies

2 other study(ies) available for sb 203580 and Peritonitis

ArticleYear
Ketamine inhibits LPS-induced HGMB1 release in vitro and in vivo.
    International immunopharmacology, 2014, Volume: 23, Issue:1

    Topics: Animals; Cecum; Cell Line; Disease Models, Animal; HMGB1 Protein; Humans; Imidazoles; Ketamine; Lipopolysaccharides; Macrophages; Male; Mice; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Peritonitis; Pyridines; Rats; Rats, Sprague-Dawley; Sepsis

2014
Mast cell chymase induces expression of chemokines for neutrophils in eosinophilic EoL-1 cells and mouse peritonitis eosinophils.
    European journal of pharmacology, 2006, May-24, Volume: 538, Issue:1-3

    Topics: Animals; Butadienes; Cell Line, Tumor; Chemokine CXCL2; Chemokines; Chymases; Cytokines; Dose-Response Relationship, Drug; Enzyme Inhibitors; Eosinophils; Gene Expression; Humans; Imidazoles; Interleukin-8; Mice; Mice, Inbred BALB C; Mitogen-Activated Protein Kinases; Neutrophils; Nitriles; Peritonitis; Pertussis Toxin; Pyridines; Quinazolines; RNA, Messenger; Serine Endopeptidases

2006